Stock Track | Bio-Techne Soars 5.04% in Pre-Market on Better-Than-Expected Quarterly Results

Stock Track

Feb 04

Bio-Techne's stock price surged 5.04% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.

The life sciences company reported quarterly adjusted earnings of $0.46 per share, beating the analyst consensus estimate of $0.43 by 5.99 percent. This represents a 9.52 percent increase compared to the same period last year. Revenue for the quarter came in at $295.877 million, also surpassing the $290.191 million estimate by 1.96 percent.

The strong performance was driven by robust demand in key segments, including double-digit growth in its large pharma end-market for the fourth consecutive quarter. The company also noted improving performance in biotech and ongoing growth in the Asia-Pacific region, particularly China, for the third straight quarter. Additionally, Bio-Techne announced a quarterly dividend of $0.08 per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1108091321"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108091321\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108091321?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-04 21:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108091321","market":"us","top_or_hot":-1,"title":"Stock Track | Bio-Techne Soars 5.04% in Pre-Market on Better-Than-Expected Quarterly Results","media":"Stock Track","content":"<p>Bio-Techne's stock price surged 5.04% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.</p><p>The life sciences company reported quarterly adjusted earnings of $0.46 per share, beating the analyst consensus estimate of $0.43 by 5.99 percent. This represents a 9.52 percent increase compared to the same period last year. Revenue for the quarter came in at $295.877 million, also surpassing the $290.191 million estimate by 1.96 percent.</p><p>The strong performance was driven by robust demand in key segments, including double-digit growth in its large pharma end-market for the fourth consecutive quarter. The company also noted improving performance in biotech and ongoing growth in the Asia-Pacific region, particularly China, for the third straight quarter. Additionally, Bio-Techne announced a quarterly dividend of $0.08 per share.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Bio-Techne Soars 5.04% in Pre-Market on Better-Than-Expected Quarterly Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Bio-Techne Soars 5.04% in Pre-Market on Better-Than-Expected Quarterly Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-04 21:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bio-Techne's stock price surged 5.04% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.</p><p>The life sciences company reported quarterly adjusted earnings of $0.46 per share, beating the analyst consensus estimate of $0.43 by 5.99 percent. This represents a 9.52 percent increase compared to the same period last year. Revenue for the quarter came in at $295.877 million, also surpassing the $290.191 million estimate by 1.96 percent.</p><p>The strong performance was driven by robust demand in key segments, including double-digit growth in its large pharma end-market for the fourth consecutive quarter. The company also noted improving performance in biotech and ongoing growth in the Asia-Pacific region, particularly China, for the third straight quarter. Additionally, Bio-Techne announced a quarterly dividend of $0.08 per share.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TECH","symbol_name":"Techne Corporation","start_time":0,"source_url":"","article_id":"1108091321","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108091321","pubTimestamp":1770213171,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Bio-Techne's stock price surged 5.04% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.The life sciences company reported quarterly...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TECH":"Techne Corporation"},"translate_title":"个股追踪|季度业绩好于预期Bio-Techne盘前大涨5.04%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TECH":1},"content_text":"Bio-Techne's stock price surged 5.04% during pre-market trading on Wednesday, following the release of its second-quarter fiscal 2026 financial results.The life sciences company reported quarterly adjusted earnings of $0.46 per share, beating the analyst consensus estimate of $0.43 by 5.99 percent. This represents a 9.52 percent increase compared to the same period last year. Revenue for the quarter came in at $295.877 million, also surpassing the $290.191 million estimate by 1.96 percent.The strong performance was driven by robust demand in key segments, including double-digit growth in its large pharma end-market for the fourth consecutive quarter. The company also noted improving performance in biotech and ongoing growth in the Asia-Pacific region, particularly China, for the third straight quarter. Additionally, Bio-Techne announced a quarterly dividend of $0.08 per share.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}